Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Feb 20, 2024 9:33am
83 Views
Post# 35888573

2 shoes to drop: What can Biden do after DEA reschedules

2 shoes to drop: What can Biden do after DEA reschedulescannabis (THC) from 1 to 3?   Let's go back to 2018 when Trump signed the Farm Act that legalized CBD at the Federal level.   Once the DEA reschedules cannabis, not only does it have huge beneficial tax implications for a pharmaceutical company developing this new class of drugs, President Biden can now sign an executive order making THC legal at the Federal level.   

So we have 2 shoes to drop, the DEA is the first shoe, Biden's executive order is the second shoe to drop and.....he will have a MASSIVE surge in popularity in the gallop polls going into the election.

The DEA is only step 1 in a 2 step process. 

Have a nice day everyone!!!
<< Previous
Bullboard Posts
Next >>